Quarterly report pursuant to Section 13 or 15(d)

Acquisition and Discontinued Operations (Narrative) (Details)

v3.8.0.1
Acquisition and Discontinued Operations (Narrative) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 12, 2016
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Business Acquisition [Line Items]            
Impairment loss on Goodwill          
Total income (loss) from discontinued operations   $ 30,922 $ (236,473) (3,563,876) $ (236,473)  
BDI [Member]            
Business Acquisition [Line Items]            
Percentage of outstanding voting stock owned by parent 98.00%          
Percentage of Venaxis common stock issued as equity consideration 14.00%          
Inventories acquired           $ 416,000
Inventories raw materials acquired           188,000
Inventories finished goods acquired           $ 228,000
Total revenue         174,000  
Net loss         $ 2,102,000  
Loss per share (Basic and Diluted)         $ 0.47  
Impairment loss on Inventory       453,000    
Impairment loss on Goodwill       430,000    
Impairment loss of Equipment and furnishings       29,000    
Impairment loss of Intangible Assests       1,833,000    
Impairment loss on other items       9,000    
Sales   $ 7,000 2,000 $ 37,000 $ 2,000  
Operating and other expenses     238,000   238,000  
Depreciation and amortization     $ 24,000   $ 24,000  
BDI [Member] | Common Stock [Member]            
Business Acquisition [Line Items]            
Equity consideration issued for acquisition, number of shares 627,010          
Value of equity consideration issued for acquisition $ 2,577,000